You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low-dose Decitabine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023

Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Low-Dose Decitabine plus anti-PD-1
  • Beijing, Beijing, China
    ChinaPLAGH
Apr 18, 2023

PFS Trial (Decitabine Injection, tirelizumab)

Not yet recruiting
  • PFS
  • (no location specified)
Nov 24, 2022

Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

Terminated
  • Refractory Aplastic Anemia
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 25, 2022

Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Jun 8, 2023

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

Objective Response Rate Trial in Hangzhou (CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine)

Recruiting
  • Objective Response Rate
  • CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 5, 2021

Response Rate Trial in Shanghai (Decitabine)

Completed
  • Response Rate
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 19, 2021

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022

Myelodysplasia, Leukemia Trial in Providence (chemo)

Terminated
Has Results
  • Myelodysplasia
  • Leukemia
  • Providence, Rhode Island
    Lifespan Hospitals
Jan 5, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Healthy Trial in San Antonio (Decitabine, Tetrahydrouridine)

Recruiting
  • Healthy
  • San Antonio, Texas
    Worldwide Clinical Trails Early Phase Services
Apr 14, 2023

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
  • Defactinib
  • Sydney, New South Wales, Australia
  • +3 more
Jan 12, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Appendicitis Acute Trial (Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT)

Not yet recruiting
  • Appendicitis Acute
  • Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT
  • (no location specified)
May 18, 2023

Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • +3 more
  • low-dose rivaroxaban
  • Standard-dose rivaroxaban
  • (no location specified)
Oct 25, 2023

Septic Shock Trial in Cairo (Normal saline, Methylene Blue low dose, Methylene Blue high dose)

Recruiting
  • Septic Shock
  • Normal saline
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Aug 15, 2023

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jul 10, 2023

Glioma Trial in Aviano (Pulsed low dose-rate radiotherapy (pLDRT))

Recruiting
  • Glioma
  • Pulsed low dose-rate radiotherapy (pLDRT)
  • Aviano, Pordenone, Italy
    IRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Sep 20, 2023